Amedisys (AMED) Projected to Post Quarterly Earnings on Wednesday

Amedisys (NASDAQ:AMEDGet Free Report) is expected to be issuing its quarterly earnings data before the market opens on Wednesday, April 23rd. Analysts expect Amedisys to post earnings of $1.13 per share and revenue of $597.43 million for the quarter.

Amedisys (NASDAQ:AMEDGet Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.09). The firm had revenue of $598.05 million during the quarter, compared to analysts’ expectations of $602.38 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. On average, analysts expect Amedisys to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Amedisys Price Performance

Shares of NASDAQ:AMED opened at $91.76 on Monday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The company has a 50-day moving average price of $92.14 and a 200 day moving average price of $91.86. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a market cap of $3.01 billion, a P/E ratio of 36.41, a PEG ratio of 1.78 and a beta of 0.89.

Analyst Ratings Changes

AMED has been the subject of a number of recent analyst reports. Royal Bank of Canada reissued an “outperform” rating and issued a $100.00 target price on shares of Amedisys in a report on Wednesday, April 16th. Stephens reiterated an “equal weight” rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $100.75.

Get Our Latest Stock Analysis on AMED

About Amedisys

(Get Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

See Also

Earnings History for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.